Vera Therapeutics Inc logo

VERA

Vera Therapeutics Inc

$36.02

Earnings Summary

Revenue
$0Mn
Net Profits
$-28.38Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Vera Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2024. On a quarterly growth basis, Vera Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Vera Therapeutics Inc’s net profit jumped 4.61% since last year same period to $-28.38Mn in the Q1 2024. On a quarterly growth basis, Vera Therapeutics Inc has generated -10.63% fall in its net profits since last 3-months.

Net Profit Margins:

Vera Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2024. On a quarterly growth basis, Vera Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Vera Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.56
EPS Estimate Current Year
-0.56

Highlights

EPS Estimate Current Quarter:

Vera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.56 - a -5.66% fall from last quarter’s estimates.

EPS Estimate Current Year:

Vera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.56.

Key Ratios

Key ratios of the Vera Therapeutics Inc post its Q1 2024 earnings

Earning Per Share (EPS)
-0.56
Return on Assets (ROA)
-0.2
Return on Equity (ROE)
-0.37

Highlights

Earning Per Share (EPS):

Vera Therapeutics Inc’s earning per share (EPS) jumped 30% since last year same period to -0.56 in the Q1 2024. This indicates that the Vera Therapeutics Inc has generated 30% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Vera Therapeutics Inc’s return on assets (ROA) stands at -0.2.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Vera Therapeutics Inc’s return on equity (ROE) stands at -0.37.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-10
-0.53
-0.56
-5.66%